Find clinical trials for Lung Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near London, England, GBR:
Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...
Phase 2
London, United Kingdom and 8 other locations
stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer.SBRT will be delivered in either 3 or 5 fractions ...
Phase 1, Phase 2
Sutton, United Kingdom
This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...
Phase 2
London, United Kingdom and 29 other locations
The trial consists of a series of parallel multi-centre single arm phase II trial arms, each testing an experimental targeted drug in a population st...
Phase 2
London, United Kingdom and 24 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
London, United Kingdom and 209 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
London, United Kingdom and 52 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
London, United Kingdom and 123 other locations
KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...
Phase 3
London, United Kingdom and 61 other locations
protein 4 \[CTLA4\] antibody \[another investigational medicinal product\]) in patients with advanced or metastasized non-small cell lung ca...
Phase 1
London, United Kingdom and 37 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
London, United Kingdom and 79 other locations
Clinical trials
Research sites
Resources
Legal